Experts Matter. Find Yours.
Connect for media, speaking, professional opportunities & more.
New light technique could revolutionise non-invasive medical diagnostics Orbital Angular Momentum could be harnessed to improve imaging and data transmission through biological tissues Could eventually have potential to make procedures such as surgery or biopsies unnecessary. An Aston University researcher has developed a new technique using light which could revolutionise non-invasive medical diagnostics and optical communication. The research showcases how a type of light called the Orbital Angular Momentum (OAM) can be harnessed to improve imaging and data transmission through skin and other biological tissues. A team led by Professor Igor Meglinski found that OAM light has unmatched sensitivity and accuracy that could result in making procedures such as surgery or biopsies unnecessary. In addition it could enable doctors to track the progression of diseases and plan appropriate treatment options. OAM is defined as a type of structured light beams, which are light fields which have a tailored spatial structure. Often referred to as vortex beams, they have previously been applied to a number of developments in different applications including astronomy, microscopy, imaging, metrology, sensing, and optical communications. Professor Meglinski in collaboration with researchers from the University of Oulu, Finland conducted the research which is detailed in the paper “Phase preservation of orbital angular momentum of light in multiple scattering environment” which is published in the Nature journal Light Science & Application. The paper has since been named as one of the year’s most exciting pieces of research by international optics and photonics membership organisation, Optica. The study reveals that OAM retains its phase characteristics even when passing through highly scattering media, unlike regular light signals. This means it can detect extremely small changes with an accuracy of up to 0.000001 on the refractive index, far surpassing the capabilities of many current diagnostic technologies. Professor Meglinski who is based at Aston Institute of Photonic Technologies said: “By showing that OAM light can travel through turbid or cloudy and scattering media, the study opens up new possibilities for advanced biomedical applications. “For example, this technology could lead to more accurate and non-invasive ways to monitor blood glucose levels, providing an easier and less painful method for people with diabetes.” The research team conducted a series of controlled experiments, transmitting OAM beams through media with varying levels of turbidity and refractive indices. They used advanced detection techniques, including interferometry and digital holography, to capture and analyse the light's behaviour. They found that the consistency between experimental results and theoretical models highlighted the ability of the OAM-based approach. The researchers believe that their study’s findings pave the way for a range of transformative applications. By adjusting the initial phase of OAM light, they believe that revolutionary advancements in fields such as secure optical communication systems and advanced biomedical imaging will be possible in the future. Professor Meglinski added: "The potential for precise, non-invasive transcutaneous glucose monitoring represents a significant leap forward in medical diagnostics. “My team’s methodological framework and experimental validations provide a comprehensive understanding of how OAM light interacts with complex scattering environments, reinforcing its potential as a versatile technology for future optical sensing and imaging challenges.” ENDS https://www.nature.com/articles/s41377-024-01562-7 Light: Science & Applications volume 13, Article number: 214 (2024) August 2024 https://doi.org/10.1038/s41377-024-01562-7 Authors: Igor Meglinski, Ivan Lopushenko, Anton Sdobnov & Alexander Bykov About Aston University For over a century, Aston University’s enduring purpose has been to make our world a better place through education, research and innovation, by enabling our students to succeed in work and life, and by supporting our communities to thrive economically, socially and culturally. Aston University’s history has been intertwined with the history of Birmingham, a remarkable city that once was the heartland of the Industrial Revolution and the manufacturing powerhouse of the world. Born out of the First Industrial Revolution, Aston University has a proud and distinct heritage dating back to our formation as the School of Metallurgy in 1875, the first UK College of Technology in 1951, gaining university status by Royal Charter in 1966, and becoming The Guardian University of the Year in 2020. Building on our outstanding past, we are now defining our place and role in the Fourth Industrial Revolution (and beyond) within a rapidly changing world. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
Aston University develops novel bone cancer therapy which has 99% success rate
Bioactive glasses, doped with gallium developed to create a potential treatment for bone cancer Lab tests have a 99 percent success rate of killing cancerous cells Method could also regenerate diseased bones. Bioactive glasses, a filling material which can bond to tissue and improve the strength of bones and teeth, has been combined with gallium to create a potential treatment for bone cancer. Tests in labs have found that bioactive glasses doped with the metal have a 99 percent success rate of eliminating cancerous cells and can even regenerate diseased bones. The research was conducted by a team of Aston University scientists led by Professor Richard Martin who is based in its College of Engineering and Physical Sciences. In laboratory tests 99% of osteosarcoma (bone cancer) cells were killed off without destroying non-cancerous normal human bone cells. The researchers also incubated the bioactive glasses in a simulated body fluid and after seven days they detected the early stages of bone formation. Gallium is highly toxic, and the researchers found that the ‘greedy’ cancer cells soak it up and self-kill, which prevented the healthy cells from being affected. Their research paper Multifunctional Gallium doped bioactive glasses: a targeted delivery for antineoplastic agents and tissue repair against osteosarcoma has been published in the journal Biomedical Materials. Osteosarcoma is the mostly commonly occurring primary bone cancer and despite the use of chemotherapy and surgery to remove tumours survival rates have not improved much since the 1970s. Survival rates are dramatically reduced for patients who have a recurrence and primary bone cancer patients are more susceptible to bone fractures. Despite extensive research on different types of bioactive glass or ceramics for bone tissue engineering, there is limited research on targeted and controlled release of anti-cancer agents to treat bone cancers. Professor Martin said: “There is an urgent need for improved treatment options and our experiments show significant potential for use in bone cancer applications as part of a multimodal treatment. “We believe that our findings could lead to a treatment that is more effective and localised, reducing side effects, and can even regenerate diseased bones. “When we observed the glasses, we could see the formation of a layer of amorphous calcium phosphate/ hydroxy apatite layer on the surface of the bioactive glass particulates, which indicates bone growth.” The glasses were created in the Aston University labs by rapidly cooling very high temperature molten liquids (1450o C) to form glass. The glasses were then ground and sieved into tiny particles which can then be used for treatment. In previous research the team achieved a 50 percent success rate but although impressive this was not enough to be a potential treatment. The team are now hoping to attract more research funding to conduct trials using gallium. Dr Lucas Souza, research laboratory manager for the Dubrowsky Regenerative Medicine Laboratory at the Royal Orthopaedic Hospital, Birmingham worked on the research with Professor Martin. He added: “The safety and effectiveness of these biomaterials will need to be tested further, but the initial results are really promising. “Treatments for a bone cancer diagnosis remain very limited and there’s still much we don’t understand. Research like this is vital to support in the development of new drugs and new methodologies for treatment options.” Notes to Editors Multifunctional Gallium doped bioactive glasses: a targeted delivery for antineoplastic agents and tissue repair against osteosarcoma Shirin B. Hanaei1, Raghavan C. Murugesan1, Lucas Souza1, Juan I.C. Miranda1, Lee Jeys2,3, Ivan B. Wall3, and Richard A. Martin1 1. College of Engineering and Physical Sciences. Aston University, Aston Triangle, Birmingham, B4 7ET, UK 2. Oncology Department, The Royal Orthopaedic Hospital, Birmingham, B31 2AP, UK 3. College of Health and Life Sciences. Aston University, Aston Triangle, Birmingham, B4 7ET, UK DOI 10.1088/1748-605X/ad76f1 About Aston University For over a century, Aston University’s enduring purpose has been to make our world a better place through education, research and innovation, by enabling our students to succeed in work and life, and by supporting our communities to thrive economically, socially and culturally. Aston University’s history has been intertwined with the history of Birmingham, a remarkable city that once was the heartland of the Industrial Revolution and the manufacturing powerhouse of the world. Born out of the First Industrial Revolution, Aston University has a proud and distinct heritage dating back to our formation as the School of Metallurgy in 1875, the first UK College of Technology in 1951, gaining university status by Royal Charter in 1966, and becoming The Guardian University of the Year in 2020. Building on our outstanding past, we are now defining our place and role in the Fourth Industrial Revolution (and beyond) within a rapidly changing world. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
National Institutes of Health award $1.827 million for research on collective cell migration
Priscilla Hwang, Ph.D., assistant professor in the Department of Biomedical Engineering at Virginia Commonwealth University, has received a National Institutes of Health grant for $1.827 million over five years. The award from the National Institute of General Medical Sciences will support Hwang’s innovative research project “Dissecting mechanisms of collective migration” and provide mentorship for student researchers from the high school to graduate level. Collective migration, where groups of cells move together in a coordinated manner, is critical for the successful development of tissues and plays a vital role in wound healing, metastasis, and other biological processes. Dysregulation in collective migration is often linked to developmental abnormalities and disease progression. Despite its importance, the mechanics and mechanisms driving collective migration remain poorly understood. The project is organized around three primary goals: Investigate the effect of biomechanical cues to activate leader cells and directional collective migration: Understand how biomechanical signals activate leader cells to guide the migration of cell groups. Elucidate which and how leader cell mechanics are responsible for leader cell development: Identify the specific mechanical properties and behaviors that enable leader cells to emerge and lead the collective migration process. Examine the role of cell junctional forces in collective migration: Explore how the forces at cell contacts contribute to the overall migration and coordination among cells. Hwang will leverage her expertise in 3D microphysiological systems to study collective migration in dynamic, physiologically relevant environments. Her work aims to uncover the mechanisms by which leader cells sense and respond to mechanical forces in their environment, driving the collective migration of cells. “Our understanding of collective migration, especially the mechanics and mechanisms driving this phenomenon, is very limited,” Hwang said. “Our proposal will significantly accelerate our progress toward a comprehensive understanding of collective migration and lay the foundation for advancing treatment for developmental abnormalities or diseases.” The NIH grant will also expand student research and mentoring opportunities. “This Maximizing Investigators Research Award (MIRA) only goes to the most highly talented and promising investigators, and Dr. Hwang is most deserving,” said Rebecca L. Heise, Ph.D., Inez A. Caudill, Jr. Distinguished Professor and chair of the Department of Biomedical Engineering . “The award will provide support for undergraduate and predoctoral research opportunities in this important area of fundamental research that has an impact on neonatal development, cancer, and fibrotic disease.” To ensure diverse perspectives are considered throughout the project, Hwang said students from diverse populations will be recruited, including underrepresented minorities, women, and first-generation college students. “Further, we will continue to share our passion for science with the community through developing hands-on outreach activities based on our research findings,” she added.
Saving Lives, One Device at a Time: Clinical Engineering
Behind every health care provider, or perhaps already in the palms of their hands, is a piece of equipment necessary to their patient’s health and survival. Modern medical treatment relies on complex equipment to keep patients alive and healthy during procedures and recovery. Take live-saving equipment such as telemetry monitors, MRI machines and ventilators as just a few examples. But what happens when all that equipment needs repair? Enter ChristianaCare’s clinical engineering technicians. This team of 35 employees — one of the largest clinical engineering teams in the nation — is responsible for overseeing the care, testing and repair of the roughly 50,000 pieces of medical equipment in use throughout the ChristianaCare system. The Clinical Engineering team is overseen by Director Blake Collins, MBA, CBET, CHTM, nationally recognized for excellence in the profession. He brings two decades of experience as a clinical engineer in the United States Navy, seven of which were served with the U.S. Marine Corps, to his role. His team has won numerous trade industry awards for its success as a “solutions provider” for the health system. "Think of health care as a triangle,” said Collins. “You have the patient, the provider and the equipment. You can’t have successful health care delivery without those three elements.” Begun in the 1970s as the hospital system’s “TV repair shop,” he joked, the Clinical Engineering department evolved dramatically after subsequent national developments in electrical safety testing and oversight for the care and functionality of medical equipment. ‘Everyone truly cares’ Today, the Clinical Engineering department maintains close to 50,000 pieces of medical equipment throughout the ChristianaCare system, including its three hospitals and all its imaging centers. “From thermometers to linear accelerators, MRIs, CTs — we manage all of it,” Collins said. Last year, the team completed 25,000 work orders, or roughly 2,100 per month. “We get to help people in so many different ways,” said John Learish, Clinical Engineering manager. Samantha Daws, Clinical Engineering supervisor, echoed the sentiment. “The Clinical Engineering Department within ChristianaCare is the most talented group of technicians I have ever had the privilege to work with,” she said. “Everyone truly cares about keeping the equipment working to ensure all caregivers have what is needed to provide quality health care to our community.” Saving lives, one device at a time What’s so important about what Clinical Engineering offers to ChristianaCare? In short: Anyone could need medical care at any time, and if medical equipment were out of commission or wrongly calibrated, lives would be at stake. Collins recalls a pivotal moment during his tenure in the Navy, when he needed an emergency appendectomy while stationed on board an aircraft carrier. “I was the only biomedical technician on the ship,” he said. “And the doctor doing the procedure asked me, jokingly, ‘Hey Collins, is this equipment going to work?’ “He was kidding, but it’s true that we never know when we or a loved one is going to end up under the equipment that we work on as engineers.” This experience gained new significance for Collins after successful open-heart surgery at ChristianaCare in 2022 — followed by his mother, who had the same procedure, also successfully, in 2023. “I had not one inkling or shadow of a doubt that the equipment was going to work fine,” he said. “You never know who will end up needing care. So we take it very, very seriously.” Icon in the field For his outstanding service as Director of Clinical Engineering at ChristianaCare, Collins was presented with the 2024 John D. Hughes Iconoclast Award from the Association for the Advancement of Medical Instrumentation (AAMI), a career-marking honor in health care technology management. The award recognizes innovation and leadership in the field; for Collins, it shows how well the Clinical Engineering team works together to deliver safe medical equipment across the ChristianaCare system. “Blake has been a relentless advocate for ChristianaCare,” read his nomination. “He has implemented numerous initiatives and processes to improve his department … and work smarter through the use of technology and automation.” The next time you see a ChristianaCare provider pick up an instrument or turn on a machine, think about the Clinical Engineering team — and rest assured that your equipment is ready to go.
Gold medal-worthy experts for Olympic Summer Games coverage
The University of Delaware boasts several experts who can comment on health-related topics such as injuries and training and business-focused areas like marketing and team behavior as they relate to the 2024 Olympic Games in Paris. Matt Robinson Professor, sport management Relevant expertise: Will be in Paris and can discuss the Olympics from an onsite perspective; can give the backstory on The International Coaching Enrichment Certificate Program (ICECP) and what’s new in the Paris Olympics. Link to profile and contact Tom Kaminski Professor, kinesiology and applied physiology Relevant expertise: Can comment on the impact of heading in Olympic soccer and has studied the risks of concussions in sports for nearly three decades. Link to profile and contact Karin Silbernagel Professor, physical therapy Relevant expertise: Research aims to advance the understanding of tendon and ligament injuries and repair. Can also discuss sailing. Link to profile and contact Tim DeSchriver Associate professor, sport management Relevant expertise: Sport finance, economics and marketing Link to profile and contact Other experts: INJURIES: Tom Buckley Associate professor, kinesiology and applied physiology Relevant expertise: Head impacts from boxing. Stephanie Cone Assistant professor, biomedical engineering Relevant expertise: Studies the structure-function relationship that exists in tendons and ligaments with a special interest in changes in this relationship during growth and following injury. Mike Eckrich Clinical instructor, physical therapy Relevant expertise: Weightlifting; can talk about the difference between men’s and women’s injuries and form in the sport. Donald Ford Physical therapy Relevant expertise: Shoulder injuries/rehab expert Jeffrey Schneider Senior instructor, kinesiology and applied physiology Relevant expertise: Athletic training and injury prevention, with a particular interest in ice skating injuries. Worked with athletes competing in Winter Olympics (2002, 2006) as a strength and conditioning coach and athletic trainer. EVENTS: Jocelyn Hafer Assistant professor, kinesiology and applied physiology Relevant expertise: Race Walk events and how biomarkers are used in walking studies. Airelle Giordano Associate professor, physical therapy Relevant expertise: Gymnastics; she was a collegiate gymnast Kiersten McCartney Doctoral student Relevant expertise: Can chat about Paralympic Triathlon (running, hand cycling, swimming). Steve Goodwin Associate professor, health behavior and nutrition sciences Relevant expertise: He is also in Paris leading a study abroad cohort. He has been to multiple Olympics, and can also speak to on-site experience, differences in games, etc. George Edelman Adjunct professor, physical therapy Relevant expertise: How the "underwaters” technique gives Olympians an edge. BUSINESS: John Allgood II Instructor, sport management Relevant expertise: Sport business management, event management SCIENCE: Joshua Cashaback Assistant professor, biomedical engineering Relevant expertise: Specializes in neuromechanics and control of human movement. His research falls under two major themes: The neuroplasticity and adaptation research line tests how reinforcement feedback can subserve our ability to acquire new motor skills.
Aston University researcher takes on leadership role within biomedical engineering
Dr Antonio Fratini is the new chair of the Institute of Mechanical Engineers Biomedical Engineering Division It is one of the largest group of professional biomedical engineers in the UK The specialism merges professional engineering with medical knowledge of the human body, such as artificial limbs and robotic surgery. An Aston University researcher has been given a leading role within the biomedical engineering sector. Dr Antonio Fratini CEng MIMechE has been elected as the new chair of the Biomedical Engineering Division (BmED) of the Institution of Mechanical Engineers (IMechE), one of the largest groups of professional biomedical engineers in the UK. The IMechE has around 115,000 members in 140 countries and has been active since 1847. Biomedical engineering, also known as medical engineering or bioengineering, is the integration of engineering with medical knowledge to help tackle clinical problems and improve healthcare outcomes. Dr Fratini previously served as chair of the Birmingham centre of the division for five years and as vice-chair of the division for one year. His research includes responsible use of AI, 3D segmentation and anatomical modelling to improve surgical training and planning, motor functions and balance rehabilitation. He leads Aston University’s Engineering for Health Research Centre within the College of Engineering and Physical Sciences and has vast experience in the design, development and testing of new medical devices. Currently he is the University’s principal investigator for the West Midlands Health Tech Innovation Accelerator and he has a growing reputation in the UK and internationally within the biomedical engineering profession. He said: “Biomedical engineering is continuously evolving and our graduates will create the future of health tech and med tech for more effective, sustainable, responsible and personalised healthcare. “I am very honoured of this appointment. This three-year post will be a great opportunity to further develop the biomedical engineering profession worldwide and to show Aston University’s commitment to an inclusive, entrepreneurial and transformational impact within the field.” Professor Helen Meese, outgoing chair of the division, said: “I am delighted to see Antonio take on the chair’s position. He has, over the years, contributed significantly to the growth of the Birmingham regional centre and has actively supported me throughout my tenure as chair. I know how passionate he is about our profession and will undoubtedly continue to drive the division forward over the next three years.” Dr Frattini was presented with his new title on 20 June at the IMECHE HQ at 1 Birdcage Walk, London during the Institution’s technology strategy board meeting. For media inquiries in relation to this release, contact Nicola Jones, Press and Communications Manager, on (+44) 7825 342091 or email: n.jones6@aston.ac.uk
Covering Earth Day - Our Experts can Help | Media Advisory
As we commemorate Earth Day, the urgency to address environmental challenges and foster sustainable practices has never been more critical. Earth Day serves as a reminder of our collective responsibility to protect and preserve our planet for future generations. This event matters to the public because it highlights the interconnectedness of environmental issues with our daily lives and underscores the importance of taking action. Here are several sub-topics that could be of interest to a broad audience: Climate change mitigation efforts and their impact on local communities Innovative technologies and initiatives for renewable energy sources Conservation efforts to protect endangered species and habitats Sustainable practices in agriculture and food production The role of businesses and corporations in promoting environmental sustainability Government policies and regulations aimed at addressing environmental challenges Connect with an Expert about Earth Day: For journalists with questions or looking to cover the streaming wars, here is a select list of experts. Bryan W. Brooks, Ph.D. Distinguished Professor, Environmental Science and Biomedical Studies; Director of Environmental Health Science · Baylor University Jase Bernhardt Associate Professor of Geology, Environment, and Sustainability · Hofstra University Saleem Ali Professor of Energy and the Environment Geography and Spatial Sciences; Biden School of Public Policy and Administration · University of Delaware Francis Galgano, PhD Associate Professor, Geography and the Environment | College of Liberal Arts and Sciences · Villanova University To search our full list of experts visit www.expertfile.com Photo Credit:Fateme Alaie
Aston University to help Saudi Arabia turn waste into energy
Energy will help power new cities in the desert Aston University is in talks about converting waste products into vital energy Its Energy and Bioproducts Institute is experienced in the waste-to-energy sector through global collaborations. Aston University researchers are to help turn waste into energy to power new cities in the desert. The University has started talks with experts from Saudi Arabia, including those who are building two sustainable cities in the desert, called NEOM and The Line. They are to collaborate with Aston University and its Energy and Bioproducts Research Institute (EBRI) to explore how they can convert waste products into vital energy. The scientists and engineers are to apply their expertise to help Saudi Arabia create technology to convert discarded matter into a source of energy and other innovations such as using date palm waste to transform desert sand to allow it to retain water and grow crops. Aston University also hosted a two-day conference in March to discuss how to develop and apply the technology. The event is a key element of the UK-KSA Waste2Energy project supported by the Foreign, Commonwealth and Development Office under the Gulf Strategy Fund (GSF) programme and is led by senior lecturer in mechanical, biomedical and design engineering Dr Muhammad Imran. More than 70 delegates attended the conference, including representatives from King Abdulaziz City for Science and Technology (KACST), King AbdulAziz University, The National Research and Development Center for Sustainable Agriculture and the Saudi Investment Recycling Company (SIRC). Professor Patricia Thornley, director of Energy & Bioproducts Research Institute, said: “The delegation chose to collaborate with and visit EBRI because we have common research goals, but some complementarity facilities and skills. We are looking forward to working together to develop some the shared priorities we have identified.” Tim Miller, EBRI director of engagement, added: “Aston University has extensive engagement in the waste-to-energy sector through substantial industrial and academic collaborations globally. Advancements made by institutes like EBRI in waste-to-energy technologies are continually contributing to sustainable energy development.” “The meeting provided an insightful overview of the project, emphasising the significant opportunities it offers to UK industries and academia for funding, collaboration and PhD opportunities. “Our special appreciation is extended to Naif Makki from the Ministry of Energy, Saudi Arabia and his colleagues for their valuable participation.” The event ended with a tour of the EBRI lab and biochar demonstrator plant and a visit to Kew Technology’s Sustainable Energy Centre in Wednesbury.
From Sci-Fi to Reality: Nanoscale Materials Pave the Way for High Precision Disease Treatment
Imagine being able to create something smaller than the size of a single strand of hair that can help treat cancer at the cellular level. Sounds like something out of a science fiction novel or movie, right? Wrong. Emily Day, with the Department of Biomedical Engineering at the University of Delaware is doing just that. Her lab innovates nanomaterials (materials with single units measuring between 1 and 100 nanometers) that enable more high precision treatment of cancer, blood disorders and other diseases. She also studies how these nanoparticle interact with with our bodies on both the subcellular-level and whole-organism level. Day has been recognized with an NSF CAREER Award along with dozens of other awards and grant honors. She is available to talk about her research and can be contacted by clicking her profile.
Inspired by Palm Trees' Resilience, Florida Tech Researcher Seeks to Strengthen Made Materials
Inspired by the tiny, circular vessels in the trunks of palm trees that allow the iconic plants to bend but not snap in strong winds, an assistant professor of aerospace engineering is researching how to recreate Mother Nature’s handiwork in additive manufacturing. Mirmilad Mirsayar received a three-year, $200,627 research grant from the National Science Foundation’s highly competitive Mechanics of Materials and Structures program under the Division of Civil, Mechanical and Manufacturing Innovation to study the mechanics and physics of crack propagation in functionally graded cellular structures made by additive manufacturing. That’s the process of creating an object by building it one layer at a time. Mirsayar is the sole principal investigator of the project, “Understanding Mixed-Mode Fracture Mechanics in Additively Manufacturable Functionally Graded Microcellular Solids.” His research is inspired by cellular patterns seen in palm trees and butterfly wings. For example, unlike oak trees and some others, the palm tree’s center contains those vessels, distributed non-uniformly throughout the trunk, that help it survive in Florida’s windy environment. Other biological systems, such as bone, honeycombs and marine sponges, also serve as inspirations from nature. “I’m enjoying this research because I’m learning from nature and I’m applying fundamentals of physics and mathematics to solve a very important engineering problem while training the next generation of engineers and researchers,” Mirsayar said. Materials with cellular structures, such as aircraft wings and artificial bones, are widely used in industries such as aerospace and biomedical. As additive manufacturing has advanced, materials with cellular structures and increasingly complex geometrical patterns can be precisely manufactured. Mirsayar is looking at ways to optimize these strong and light cellular structures made by additive manufacturing to achieve the highest resistance against failure under complex operational loading conditions, such as bending tension, compression and torsion. What could this mean for additive manufacturing? How could stronger materials change what or how we build? Contact Florida Tech Media Communications Director Adam Lowenstein at adam@fit.edu to schedule an interview with Dr. Mirsayar.
